Market Research > Industries > Healthcare

Market Research: Nonprescription Drugs USA 2008

Nonprescription Drugs USA 2008

Published June 2009

View PDF brochure
View fact sheet

This comprehensive annual survey is considered the authoritative source of information on the nonprescription drugs industry. It contains sales data on hundreds of OTC brands and companies, new product and ad spending analysis, retail distribution, five years historical sales and sales forecasts for 36 major product categories; detailed profiles of 15 leading marketers; 50 minor companies; an analysis of media spending; and timely bulletins covering new products and corporate developments. (CIA6G)

	ORDER ONLINE

You may submit an online request to subscribe to sections of this report, using a simple three-step process. After submitting your online request, you will then be contacted by a member of our global sales team to confirm the final price, and complete the transaction. Upon acceptance of your order, we will deliver the files in pdf format via email.

STEP 1 of 3

– Select the sections in which you are interested by clicking on the appropriate boxes:

FULL REPORT [US$ 33600 (thirty three thousand six hundred US Dollars)]

INTRODUCTION [US$ 0]

INDUSTRY ANALYSIS [US$ 7 000]

The Market [US$ 1 500]

Table 3-1 MANUFACTURERS’ SALES OF NONPRESCRIPTION DRUGS, 2003 TO 2008

Table 3-2 MANUFACTURERS’ SALES OF NONPRESCRIPTION DRUGS BY CATEGORY, 2008

Table 3-3 UNIT SALES OF NONPRESCRIPTION DRUGS BY CATEGORY, 2007 AND 2008

Table 3-4 MANUFACTURERS’ SALES OF NONPRESCRIPTION DRUGS WITH PERCENTAGE GROWTH, 2007 AND 2008

Table 3-5 PERCENTAGE GROWTH OF MANUFACTURERS’ SALES BY PRODUCT CATEGORY, 2007 AND 2008

Table 3-6 SALES OF TOP 25 NONPRESCRIPTION BRANDS, 2007 AND 2008

Companies [US$ 1 500]

Table 3-7 MAJOR COMPANIES’ NONPRESCRIPTION DRUG SALES, 2007 AND 2008

Table 3-8 ESTIMATED U.S. SALES OF NONPRESCRIPTION DRUGS AND TOTAL SALES OF 15 LEADING COMPANIES, 2008

Table 3-9 SALES OF LEADING NONPRESCRIPTION DRUG COMPANIES BY PRODUCT CLASS, 2008

Table 3-10 NONPRESCRIPTION DRUG SALES OF THE 14 LEADING COMPANIES BY PRODUCT CLASS, 2008

Table 3-11 ESTIMATED U.S. SALES OF NONPRESCRIPTION DRUGS BY LEADING COMPANY, 2007 TO 2008

Selling and Distribution [US$ 1 200]

Table 3-12 PERCENTAGE OF DOLLAR SALES OF NONPRESCRIPTION DRUGS BY TYPE OF RETAIL OUTLET, 2008

Table 3-13 U.S. SALES OF NONPRESCRIPTION DRUGS

BY TYPE OF RETAIL OUTLET, 2008

Private-label Activity [US$ 1 200]

Table 3-14 GROWTH OF PRIVATE-LABEL SALES AND PERCENTAGE OF TOTAL PRIVATE-LABEL SALES, 2007 AND 2008

Table 3-15 PRIVATE-LABEL SALES OF NONPRESCRIPTION DRUGS AS A PERCENTAGE OF CATEGORY SALES, 2008

Promotion [US$ 1 500]

Table 3-16 TRACEABLE MEDIA EXPENDITURES OF NONPRESCRIPTION DRUGS, 2007 AND 2008

Table 3-17 LEADING NONPRESCRIPTION DRUG COMPANIES RANKED BY TRACEABLE MEDIA EXPENDITURES, 2008

Table 3-18 TRACEABLE MEDIA EXPENDITURES OF NONPRESCRIPTION DRUGS AS A PERCENTAGE OF PRODUCT CATEGORY SALES, 2008

Table 3-19 THE 25 MOST ADVERTISED BRANDS BY TRACEABLE MEDIA EXPENDITURES, 2008

Outlook [US$ 1 500]

Table 3-20 HISTORICAL AND FORECAST GROWTH OF THE NONPRESCRIPTION DRUGS INDUSTRY, 2003 TO 2013

Table 3-21 FORECAST U.S. UNIT SALES OF NONPRESCRIPTION DRUGS BY RATE OF GROWTH, 2008 TO 2013

Table 3-22 FORECAST U.S. DOLLAR SALES OF NONPRESCRIPTION DRUGS BY RATE OF GROWTH, 2008 TO 2013

Kline's FutureView Forecasting Scenarios for the Nonprescription Drugs Industry [US$ 1 500]

Figure 3-1 FORECAST NONPRESCRIPTION DRUG SALES, 2008 TO 2013

Table 3-23 NONPRESCRIPTION DRUGS INDUSTRY TOTAL DOLLAR SALES FORECASTS, 2008 TO 2013

Table 3-24 FUTUREVIEW SCENARIO FORECASTS FOR ALLERGY, ASTHMA, AND SINUS PRODUCTS SALES, 2008 TO 2013

Figure 3-2 FUTUREVIEW SCENARIO FORECASTS FOR DOLLAR SALES OF ALLERGY, ASTHMA, AND SINUS PRODUCTS, 2008 TO 2013

Table 3-25 FUTUREVIEW SCENARIO FORECASTS FOR COUGH AND COLD PREPARATIONS SALES, 2008 TO 2013

Figure 3-3 FUTUREVIEW SCENARIO FORECASTS FOR DOLLAR SALES OF COUGH AND COLD PREPARATIONS, 2008 TO 2013

Table 3-26 FUTUREVIEW SCENARIO FORECASTS FOR DIGESTIVE PRODUCTS SALES, 2008 TO 2013

Figure 3-4 FUTUREVIEW SCENARIO FORECASTS FOR DOLLAR SALES OF DIGESTIVE PRODUCTS, 2008 TO 2013

Table 3-27 FUTUREVIEW SCENARIO FORECASTS FOR FEMININE PRODUCTS SALES, 2008 TO 2013

Figure 3-5 FUTUREVIEW SCENARIO FORECASTS FOR DOLLAR SALES OF FEMININE PRODUCTS, 2008 TO 2013

Table 3-28 FUTUREVIEW SCENARIO FORECASTS FOR INTERNAL ANALGESICS SALES, 2008 TO 2013

Figure 3-6 FUTUREVIEW SCENARIO FORECASTS FOR DOLLAR SALES OF INTERNAL ANALGESICS, 2008 TO 2013

Table 3-29 FUTUREVIEW SCENARIO FORECASTS FOR NUTRITIONAL PRODUCTS SALES, 2008 TO 2013

Figure 3-7 FUTUREVIEW SCENARIO FORECASTS FOR DOLLAR SALES OF NUTRITIONAL PRODUCTS, 2008 TO 2013

Table 3-30 FUTUREVIEW SCENARIO FORECASTS FOR TOPICAL PRODUCTS SALES, 2008 TO 2013

Figure 3-8 FUTUREVIEW SCENARIO FORECASTS FOR DOLLAR SALES OF TOPICAL PRODUCTS, 2008 TO 2013

Table 3-31 FUTUREVIEW SCENARIO FORECASTS FOR OTHER PRODUCTS SALES, 2008 TO 2013

igure 3-9 FUTUREVIEW SCENARIO FORECASTS FOR DOLLAR SALES OF OTHER PRODUCTS, 2008 TO 2013

Table 3-32 POPULATION GROWTH INCLUDING IMMIGRATION BY AGE, 2008 TO 2013

THE PRODUCTS [US$ 15 000]

Introduction - The Products [US$ 0]

Table 4A-1 CROSS REFERENCE OF MAJOR PHARMACEUTICAL SUBSIDIARIES AND DIVISIONS WITH PARENT COMPANIES, 2008

The Market [US$ 1 800]

Table 4B-1 U.S. SALES OF NONPRESCRIPTION DRUGS BY CATEGORY, 2007 AND 2008

Figure 4B-1 MANUFACTURERS’ SALES OF NONPRESCRIPTION DRUGS BY PRODUCT CLASS, 2008

Allergy, Asthma, and Sinus Products [US$ 4 000]

Table 4C-1 MANUFACTURERS’ SALES OF ALLERGY, ASTHMA, AND SINUS PRODUCTS BY PRODUCT CATEGORY, 2007 AND 2008

Figure 4C-1 MANUFACTURERS’ SALES OF ALLERGY, ASTHMA, AND SINUS PRODUCTS, 2008

Table 4C-2 MANUFACTURERS’ SALES OF MAJOR ALLERGY, ASTHMA, AND SINUS PRODUCTS BY PRODUCT CATEGORY AND COMPANY, 2008

Table 4C-3 DISTRIBUTION OF ALLERGY, ASTHMA, AND SINUS PRODUCTS BY RETAIL OUTLET, 2008

Table 4C-4 FUTUREVIEW SCENARIO FORECASTS FOR ALLERGY, ASTHMA, AND SINUS PRODUCT SALES, 2008 TO 2013

Figure 4C-2 FUTUREVIEW SCENARIO FORECASTS FOR DOLLAR SALES OF ALLERGY, ASTHMA, AND SINUS PRODUCTS, 2003 TO 2013
Allergy relief products [US$ 3 000]

Table 4C-5 MANUFACTURERS’ SALES OF ALLERGY RELIEF PRODUCTS BY BRAND, 2007 AND 2008

Table 4C-6 NEW ALLERGY RELIEF PRODUCTS INTRODUCED IN 2008

Table 4C-7 MANUFACTURERS’ SALES OF ALLERGY RELIEF PRODUCTS BY COMPANY, 2007 AND 2008

Table 4C-8 DISTRIBUTION OF ALLERGY RELIEF PRODUCTS BY RETAIL OUTLET, 2007 AND 2008

Asthma medications [US$ 1 000]

Table 4C-9 MANUFACTURERS’ SALES OF ASTHMA MEDICATIONS BY BRAND, 2007 AND 2008

Table 4C-10 DISTRIBUTION OF ASTHMA MEDICATIONS BY RETAIL OUTLET, 2007 AND 2008

Sinus medications [US$ 1 000]

Table 4C-11 MANUFACTURERS’ SALES OF SINUS MEDICATIONS BY BRAND, 2007 AND 2008

Table 4C-12 NEW SINUS PRODUCTS INTRODUCED IN 2008

Table 4C-13 DISTRIBUTION OF SINUS MEDICATIONS BY RETAIL OUTLET, 2007 AND 2008

Cough and Cold Preparations [US$ 6 000]

Table 4D-1 MANUFACTURERS SALES OF COUGH AND COLD PREPARATIONS BY PRODUCT CATEGORY, 2007 AND 2008

Figure 4D-1 MANUFACTURERS’ SALES OF COUGH AND COLD PREPARATIONS, 2008

Table 4D-2 MANUFACTURERS’ SALES OF MAJOR COUGH AND COLD PREPARATIONS BY PRODUCT CATEGORY AND COMPANY, 2008

Table 4D-3 SALES OF COUGH AND COLD PREPARATIONS BY RETAIL OUTLET AND PRODUCT CATEGORY, 2008

Table 4D-4 FUTUREVIEW SCENARIO FORECASTS FOR COUGH AND COLD PREPARATION SALES, 2008 TO 2013

Figure 4D-2 FUTUREVIEW SCENARIO FORECASTS FOR DOLLAR SALES OF COUGH AND COLD PREPARATIONS, 2003 TO 2013

Cold medications [US$ 3 000]

Table 4D-5 MANUFACTURERS’ SALES OF COLD MEDICATIONS BY SEGMENT AND BRAND, 2007 AND 2008

Table 4D-6 NEW COLD MEDICATIONS INTRODUCED IN 2008

Table 4D-7 MANUFACTURERS’ SALES OF COLD MEDICATIONS BY BRAND, 2007 AND 2008

Table 4D-8 MANUFACTURERS’ SALES OF COLD MEDICATIONS BY COMPANY, 2007 AND 2008

Table 4D-9 DISTRIBUTION OF COLD MEDICATIONS BY RETAIL OUTLET, 2007 AND 2008

Cough drops and lozenges [US$ 1 000]

Table 4D-10 MANUFACTURERS SALES OF COUGH DROPS AND LOZENGES BY BRAND, 2007 AND 2008

Table 4D-11 NEW COUGH DROPS AND LOZENGES INTRODUCED IN 2008

Table 4D-12 DISTRIBUTION OF COUGH DROPS AND LOZENGES BY RETAIL OUTLET, 2007 AND 2008

Cough syrups [US$ 1 500]

Table 4D-13 MANUFACTURERS’ SALES OF COUGH SYRUPS BY SEGMENT AND BRAND, 2007 AND 2008

Table 4D-14 NEW COUGH SYRUPS INTRODUCED IN 2008

Table 4D-15 MANUFACTURERS’ SALES OF COUGH SYRUPS BY COMPANY, 2007 AND 2008

Table 4D-16 DISTRIBUTION OF COUGH SYRUPS BY RETAIL OUTLET, 2007 AND 2008

Nasal decongestants [US$ 1 000]

Table 4D-17 MANUFACTURERS’ SALES OF NASAL DECONGESTANTS BY SEGMENT AND BRAND, 2007 AND 2008

Table 4D-18 NEW NASAL DECONGESTANTS INTRODUCED IN 2008

Table 4D-19 MANUFACTURERS’ SALES OF NASAL DECONGESTANTS BY COMPANY, 2008

Table 4D 20 DISTRIBUTION OF NASAL DECONGESTANTS BY RETAIL OUTLET, 2007 AND 2008

Sore throat remedies [US$ 1 000]

Table 4D-21 MANUFACTURERS’ SALES OF SORE THROAT REMEDIES BY SEGMENT AND BRAND, 2007 AND 2008

Table 4D-22 NEW SORE THROAT REMEDIES INTRODUCED IN 2008

Table 4D-23 DISTRIBUTION OF SORE THROAT REMEDIES BY RETAIL OUTLET, 2007 AND 2008

Topical vapor products [US$ 1 000]

Table 4D-24 MANUFACTURERS’ SALES OF TOPICAL VAPOR PRODUCTS BY SEGMENT AND BRAND, 2007 AND 2008

Table 4D-25 NEW TOPICAL VAPOR PRODUCTS INTRODUCED IN 2008

Table 4D-26 DISTRIBUTION OF TOPICAL VAPOR PRODUCTS BY RETAIL OUTLET, 2007 AND 2008

Digestive Products [US$ 5 000]

Table 4E-1 MANUFACTURERS’ SALES OF DIGESTIVE PRODUCTS BY PRODUCT CATEGORY, 2007 AND 2008

Figure 4E-1 MANUFACTURERS’ SALES OF DIGESTIVE PRODUCTS, 2008

Table 4E-2 MANUFACTURERS’ SALES OF DIGESTIVE PRODUCTS BY PRODUCT CATEGORY AND COMPANY, 2008

Table 4E-3 DISTRIBUTION OF DIGESTIVE PRODUCTS BY RETAIL OUTLET, 2008

Table 4E-4 FUTUREVIEW SCENARIO FORECASTS FOR DIGESTIVE PRODUCTS SALES, 2008 TO 2013

Figure 4E-2 FUTUREVIEW SCENARIO FORECASTS FOR DOLLAR SALES OF DIGESTIVE PRODUCTS, 2003 TO 2013
Antacids and antigas products [US$ 3 000]

Table 4E-5 MANUFACTURERS’ SALES OF ANTACIDS AND ANTIGAS PRODUCTS BY SEGMENT AND BRAND, 2007 AND 2008

Table 4E-6 NEW ANTACIDS AND ANTIGAS PRODUCTS LAUNCHED IN 2008

Table 4E-7 MANUFACTURERS’ SALES OF ANTACIDS AND ANTIGAS PRODUCTS BY COMPANY, 2007 AND 2008

Table 4E-8 MANUFACTURERS’ SALES OF ANTACIDS AND ANTIGAS PRODUCTS BY BRAND, 2007 AND 2008

Table 4E-9 DISTRIBUTION OF ANTACIDS AND ANTIGAS BY RETAIL OUTLET, 2007 AND 2008

Antidiarrheal preparations [US$ 1 000]

Table 4E-10 MANUFACTURERS’ SALES OF ANTIDIARRHEAL PREPARATIONS BY BRAND, 2007 AND 2008

Table 4E-11 DISTRIBUTION OF ANTIDIARRHEAL PREPARATIONS BY RETAIL OUTLET, 2007 AND 2008

Antinausea preparations [US$ 1 000]

Table 4E-12 MANUFACTURERS’ SALES OF ANTINAUSEA PREPARATIONS BY BRAND, 2007 AND 2008

Table 4E-13 DISTRIBUTION OF ANTINAUSEA PREPARATIONS BY RETAIL OUTLET, 2007 AND 2008

Laxatives [US$ 2 000]

Table 4E-14 MANUFACTURERS’ SALES OF LAXATIVES BY SEGMENT AND BRAND, 2007 AND 2008

Table 4E-15 CATEGORY I INGREDIENTS FOR LAXATIVES

Table 4E-16 NEW LAXATIVES LAUNCHED IN 2008

Table 4E-17 DISTRIBUTION OF LAXATIVES BY RETAIL OUTLET, 2007 AND 2008

Feminine Products [US$ 3 000]

Table 4F-1 MANUFACTURERS’ SALES OF FEMININE PRODUCTS BY PRODUCT CATEGORY, 2007 AND 2008

Figure 4F-1 MANUFACTURERS’ SALES OF FEMININE PRODUCTS, 2008

Table 4F-2 MANUFACTURERS’ SALES OF MAJOR FEMININE PRODUCTS BY PRODUCT CATEGORY AND COMPANY, 2008

Table 4F-3 DISTRIBUTION OF FEMININE PRODUCTS BY RETAIL OUTLET, 2008

Table 4F-4 FUTUREVIEW SCENARIO FORECASTS FOR FEMININE PRODUCT SALES, 2008 TO 2013

Figure 4F-2 FUTUREVIEW SCENARIO FORECASTS FOR DOLLAR SALES OF FEMININE PRODUCTS, 2003 TO 2013
Contraceptive products [US$ 1 500]

Table 4F-5 MANUFACTURERS’ SALES OF CONTRACEPTIVE PRODUCTS BY SEGMENT AND BRAND, 2007 AND 2008

Table 4F-6 DISTRIBUTION OF CONTRACEPTIVE PRODUCTS BY RETAIL OUTLET, 2007 AND 2008

Feminine deodorants and itching remedies [US$ 1 000]

Table 4F-7 MANUFACTURERS’ SALES OF FEMININE DEODORANTS AND ITCHING REMEDIES BY SEGMENT AND BRAND, 2007 AND 2008

Table 4F-8 DISTRIBUTION OF FEMININE DEODORANTS AND ITCHING REMEDIES BY RETAIL OUTLET, 2007 AND 2008

Feminine yeast infection remedies [US$ 1 500]

Table 4F-9 MANUFACTURERS’ SALES OF FEMININE YEAST INFECTION REMEDIES BY SEGMENT AND BRAND, 2007 AND 2008

Table 4F-10 DISTRIBUTION OF FEMININE YEAST INFECTION REMEDIES BY RETAIL OUTLET, 2007 AND 2008

Personal lubricants [US$ 1 000]

Table 4F-11 MANUFACTURERS’ SALES OF PERSONAL LUBRICANTS BY SEGMENT AND BRAND, 2007 AND 2008

Table 4F-12 NEW PERSONAL LUBRICANTS LAUNCHED IN 2008

Table 4F-13 DISTRIBUTION OF PERSONAL LUBRICANTS BY RETAIL OUTLET, 2007 AND 2008

Internal Analgesics [US$ 3 000]

Table 4G-1 MANUFACTURERS SALES OF INTERNAL ANALGESICS BY PRODUCT CATEGORY, 2007 AND 2008

Figure 4G-1 MANUFACTURERS’ SALES OF INTERNAL ANALGESICS, 2008

Table 4G-2 MANUFACTURERS’ SALES OF MAJOR INTERNAL ANALGESICS BY PRODUCT CATEGORY AND COMPANY, 2008

Table 4G-3 SALES OF INTERNAL ANALGESICS BY RETAIL OUTLET AND CATEGORY, 2008

Table 4G-4 FUTUREVIEW SCENARIO FORECASTS FOR INTERNAL ANALGESICS SALES, 2008 TO 2013

Figure 4G-2 FUTUREVIEW SCENARIO FORECASTS FOR DOLLAR SALES OF INTERNAL ANALGESICS, 2003 TO 2013
Arthritis pain relievers [US$ 1 000]

Table 4G-5 MANUFACTURERS’ SALES OF ARTHRITIS PAIN RELIEVERS BY BRAND, 2007 AND 2008

Table 4G-6 DISTRIBUTION OF ARTHRITIS PAIN RELIEVERS BY RETAIL OUTLET, 2007 AND 2008

General pain relievers [US$ 2 000]

Table 4G-7 MANUFACTURERS’ SALES OF GENERAL PAIN RELIEVERS BY SEGMENT AND BRAND, 2007 AND 2008

Table 4G-8 NEW GENERAL PAIN RELIEVERS INTRODUCED IN 2008

Table 4G-9 MANUFACTURERS’ SALES OF GENERAL PAIN RELIEVERS BY BRAND, 2007 AND 2008

Table 4G-10 MANUFACTURERS’ SALES OF GENERAL PAIN RELIEVERS BY COMPANY, 2007 AND 2008

Table 4G-11 SALES OF GENERAL PAIN RELIEVERS BY ACTIVE INGREDIENT, 2007 AND 2008

Table 4G-12 DISTRIBUTION OF GENERAL PAIN RELIEVERS BY RETAIL OUTLET, 2007 AND 2008

Menstrual relief products [US$ 1 000]

Table 4G-13 MANUFACTURERS’ SALES OF MENSTRUAL RELIEF PRODUCTS BY SEGMENT AND BRAND, 2007 AND 2008

Table 4G-14 DISTRIBUTION OF MENSTRUAL RELIEF PRODUCTS BY RETAIL OUTLET, 2007 AND 2008

Nutritional Products [US$ 4 500]

Table 4H-1 MANUFACTURERS’ SALES OF NUTRITIONAL PRODUCTS BY PRODUCT CATEGORY, 2007 AND 2008

Figure 4H-1 MANUFACTURERS’ SALES OF NUTRITIONAL PRODUCTS, 2008

Table 4H-2 MANUFACTURERS’ SALES OF NUTRITIONAL PRODUCTS BY PRODUCT CATEGORY AND COMPANY, 2008

Table 4H 3 RETAIL DISTRIBUTION OF NUTRITIONAL PRODUCTS BY RETAIL OUTLET, 2008

Table 4H-4 FUTUREVIEW SCENARIO FORECASTS FOR NUTRITIONAL PRODUCT SALES, 2008 TO 2013

Figure 4H-2 FUTUREVIEW SCENARIO FORECASTS FOR DOLLAR SALES OF NUTRITIONAL PRODUCTS, 2003 TO 2013
Herbal products [US$ 3 000]

Table 4H-5 MANUFACTURERS’ SALES OF HERBAL PRODUCTS BY SEGMENT AND BRAND, 2007 AND 2008

Table 4H-6 NEW HERBAL PRODUCTS INTRODUCED IN 2008

Table 4H-7 PRIVATE-LABEL SALES OF HERBAL PRODUCTS BY SEGMENT, 2007 AND 2008

Table 4H-8 DISTRIBUTION OF HERBAL PRODUCTS BY RETAIL OUTLET, 2007 AND 2008

Vitamins and minerals [US$ 3 000]

Table 4H-9 MANUFACTURERS’ SALES OF VITAMINS AND MINERALS BY PRODUCT TYPE, 2007 AND 2008

Table 4H-10 NEW VITAMINS AND MINERALS INTRODUCED IN 2008

Table 4H-11 MANUFACTURERS’ SALES OF VITAMINS AND MINERALS BY COMPANY, 2007 AND 2008

Table 4H-12 MANUFACTURERS’ SALES OF VITAMINS AND MINERALS BY SEGMENT AND BRAND, 2007 AND 2008

Table 4H-13 PRIVATE-LABEL SALES OF VITAMINS AND MINERALS BY SEGMENT, 2008

Table 4H-14 DISTRIBUTION OF VITAMINS AND MINERALS BY RETAIL OUTLET, 2007 AND 2008

Topical Products [US$ 7 000]

Figure 4I-1 MANUFACTURERS’ SALES OF TOPICAL PRODUCTS BY PRODUCT CATEGORY, 2008

Table 4I-1 MANUFACTURERS’ SALES OF TOPICAL PRODUCTS BY PRODUCT CATEGORY, 2007 AND 2008

Table 4I-2 MANUFACTURERS’ SALES OF TOPICAL PRODUCTS BY PRODUCT CATEGORY AND COMPANY, 2008

Table 4I-3 SALES OF TOPICAL PRODUCTS BY RETAIL OUTLET AND PRODUCT CATEGORY, 2008

Table 4I-4 FUTUREVIEW SCENARIO FORECASTS FOR TOPICAL PRODUCT SALES, 2008 TO 2013

Figure 4I-2 FUTUREVIEW SCENARIO FORECASTS FOR DOLLAR SALES OF TOPICAL PRODUCTS, 2003 TO 2013
Anti-itch products [US$ 1 000]

Table 4I-5 MANUFACTURERS’ SALES OF ANTI-ITCH PRODUCTS BY SEGMENT AND BRAND, 2007 AND 2008

Table 4I-6 NEW ANTI-ITCH PRODUCTS INTRODUCED IN 2008

Table 4I-7 DISTRIBUTION OF ANTI-ITCH PRODUCTS BY RETAIL OUTLET, 2007 AND 2008

Corn, callus, and wart removers [US$ 1 000]

Table 4I-8 MANUFACTURERS’ SALES OF CORN, CALLUS, AND WART REMOVERS BY SEGMENT AND BRAND, 2007 AND 2008

Table 4I-9 DISTRIBUTION OF CORN, CALLUS, AND WART REMOVERS BY RETAIL OUTLET, 2007 AND 2008

Diaper rash products [US$ 1 000]

Table 4I-10 MANUFACTURERS’ SALES OF DIAPER RASH PRODUCTS BY BRAND, 2007 AND 2008

Table 4I-11 DISTRIBUTION OF DIAPER RASH PRODUCTS BY RETAIL OUTLET, 2007 AND 2008

Eye care products [US$ 1 500]

Table 4I-12 MANUFACTURERS’ SALES OF EYE CARE PRODUCTS BY BRAND AND SEGMENT, 2007 AND 2008

Table 4I-13 NEW EYE CARE PRODUCTS INTRODUCED IN 2008

Table 4I-14 DISTRIBUTION OF EYE CARE PRODUCTS BY RETAIL OUTLET, 2007 AND 2008

First aid products [US$ 1 500]

Table 4I-15 MANUFACTURER’S SALES OF FIRST AID PRODUCTS BY SEGMENT AND BRAND, 2007 AND 2008

Table 4I-16 DISTRIBUTION OF FIRST AID PRODUCTS BY RETAIL OUTLET, 2007 AND 2008

Fungicidal preparations [US$ 1 500]

Table 4I-17 MANUFACTURERS’ SALES OF FUNGICIDAL PREPARATIONS BY SEGMENT AND BRAND, 2007 AND 2008

Table 4I-18 DISTRIBUTION OF FUNGICIDAL PREPARATIONS BY RETAIL OUTLET, 2007 AND 2008

Hair regrowth treatments [US$ 1 000]

Table 4I-19 MANUFACTURERS’ SALES OF HAIR REGROWTH TREATMENTS BY BRAND, 2007 AND 2008

Table 4I-20 DISTRIBUTION OF HAIR REGROWTH TREATMENTS BY RETAIL OUTLET, 2007 AND 2008

Hemorrhoidal preparations [US$ 1 000]

Table 4I-21 MANUFACTURERS’ SALES OF HEMORRHOIDAL PREPARATIONS BY BRAND, 2007 AND 2008

Table 4I-22 DISTRIBUTION OF HEMORRHOIDAL PREPARATIONS BY RETAIL OUTLET, 2007 AND 2008

Oral care products [US$ 1 000]

Table 4I-23 MANUFACTURERS’ SALES OF ORAL CARE PRODUCTS BY BRAND, 2007 AND 2008

Table 4I-24 DISTRIBUTION OF ORAL CARE PRODUCTS BY RETAIL OUTLET, 2007 AND 2008

Topical analgesics [US$ 1 500]

Table 4I-25 MANUFACTURERS’ SALES OF TOPICAL ANALGESICS BY BRAND, 2007 AND 2008

Table 4I-26 NEW TOPICAL ANALGESICS INTRODUCED IN 2008

Table 4I-27 DISTRIBUTION OF TOPICAL ANALGESICS BY RETAIL OUTLET, 2007 AND 2008

Other Products [US$ 4 500]

Table 4J-1 MANUFACTURERS’ SALES OF OTHER PRODUCTS BY PRODUCT CATEGORY, 2007 AND 2008

Figure 4J-1 MANUFACTURERS’ SALES OF OTHER PRODUCTS, 2008

Table 4J-2 MANUFACTURERS’ SALES OF MAJOR OTHER PRODUCTS BY PRODUCT CATEGORY AND COMPANY, 2008

Table 4J 3 DISTRIBUTION OF OTHER PRODUCTS BY RETAIL OUTLET, 2008

Table 4J-4 FUTUREVIEW SCENARIO FORECASTS FOR OTHER PRODUCT SALES, 2008 TO 2013

Figure 4J-2 FUTUREVIEW SCENARIO FORECASTS FOR DOLLAR SALES OF OTHER PRODUCTS, 2003 TO 2013
Home diagnostic test kits [US$ 3 000]

Table 4J-5 MANUFACTURERS’ SALES OF HOME DIAGNOSTIC TEST KITS, 2007 AND 2008

Table 4J-6 NEW HOME DIAGNOSTIC TEST KITS INTRODUCED IN 2008

Table 4J-7 MANUFACTURERS’ SALES OF HOME DIAGNOSTIC TEST KITS BY COMPANY, 2008

Table 4J-8 PRIVATE-LABEL SALES OF HOME DIAGNOSTIC TEST KITS BY SEGMENT, 2007 AND 2008

Table 4J-9 DISTRIBUTION OF HOME DIAGNOSTIC TEST KITS BY RETAIL OUTLET, 2007 AND 2008

Sleeping aids [US$ 1 000]

Table 4J-10 MANUFACTURERS’ SALES OF SLEEPING AIDS BY BRAND, 2007 AND 2008

Table 4J-11 DISTRIBUTION OF SLEEPING AIDS BY RETAIL OUTLET, 2007 AND 2008

Smoking cessation aids [US$ 1 500]

Table 4J-12 MANUFACTURERS’ SALES OF SMOKING CESSATION AIDS BY SEGMENT AND BRAND, 2007 AND 2008

Table 4J-13 DISTRIBUTION OF SMOKING CESSATION AIDS BY RETAIL OUTLET, 2007 AND 2008

Weight loss medications [US$ 1 000]

Table 4J-14 DISTRIBUTION OF WEIGHT LOSS MEDICATIONS BY RETAIL OUTLET, 2007 AND 2008

MAJOR COMPANIES [US$ 13 000]

Introduction - Major Companies [US$ 0]

Table 5-1 CROSS REFERENCE OF MAJOR PHARMACEUTICAL SUBSIDIARIES AND DIVISIONS WITH PARENT COMPANIES, 2008

Overview [US$ 3 200]

Table 5-2 MANUFACTURERS’ SALES OF NONPRESCRIPTION DRUGS BY COMPANY, 2008

Table 5-3 ESTIMATED DOMESTIC MANUFACTURERS’ SALES OF NONPRESCRIPTION DRUGS WITH PERCENTAGE GROWTH OF LEADING COMPANIES, 2007 AND 2008

Abbott Laboratories [US$ 1 000]

Table 5-4 ABBOTT LABORATORIES’ SALES OF NONPRESCRIPTION DRUGS, 2007 AND 2008

Table 5-5 NONPRESCRIPTION DRUG BRANDS OF ABBOTT LABORATORIES, 2008

Table 5-6 SELECT NEW PRODUCTS INTRODUCED BY ABBOTT LABORATORIES IN 2008

Bayer Group [US$ 2 500]

Table 5-7 BAYER GROUP’S SALES OF NONPRESCRIPTION DRUGS, 2007 AND 2008

Table 5-8 NONPRESCRIPTION DRUGS OF BAYER GROUP, 2008

Table 5-9 SELECT NEW PRODUCTS INTRODUCED BY BAYER GROUP IN 2008

Table 5-10 FORECAST DOLLAR SALES GROWTH FOR NONPRESCRIPTION DRUGS OF BAYER GROUP BY CATEGORY, 2008 TO 2013

Boehringer-Ingelheim [US$ 1 000]

Table 5-11 BOEHRINGER-INGELHEIM’S SALES OF NONPRESCRIPTION DRUGS, 2007 AND 2008

Table 5-12 NONPRESCRIPTION DRUGS OF BOEHRINGER-INGELHEIM, 2008

Table 5-13 FORECAST DOLLAR SALES GROWTH FOR NONPRESCRIPTION DRUGS OF BOEHRINGER-INGELHEIM BY CATEGORY, 2008 TO 2013

Chattem [US$ 1 000]

Table 5-14 CHATTEM’S SALES OF NONPRESCRIPTION DRUGS, 2007 AND 2008

Table 5-15 NONPRESCRIPTION DRUGS OF CHATTEM, 2008

Table 5-16 SELECT NEW PRODUCTS INTRODUCED BY CHATTEM IN 2008

Table 5-17 FORECAST DOLLAR SALES GROWTH FOR NONPRESCRIPTION DRUGS OF CHATTEM BY CATEGORY, 2008 TO 2013

GlaxoSmithKline [US$ 2 500]

Table 5-18 GLAXOSMITHKLINE’S SALES OF NONPRESCRIPTION DRUGS, 2007 AND 2008

Table 5-19 NONPRESCRIPTION DRUGS OF GLAXOSMITHKLINE, 2008

Table 5-20 NEW PRODUCTS INTRODUCED BY GLAXOSMITHKLINE IN 2008

Table 5-21 FORECAST DOLLAR SALES GROWTH FOR NONPRESCRIPTION DRUGS OF GLAXOSMITHKLINE BY CATEGORY, 2008 TO 2013

Johnson & Johnson [US$ 2 500]

Table 5-22 JOHNSON & JOHNSON’S SALES OF NONPRESCRIPTION DRUGS, 2007 AND 2008

Table 5-23 NONPRESCRIPTION DRUGS OF JOHNSON & JOHNSON, 2008

Table 5-24 SELECT NEW PRODUCTS INTRODUCED BY JOHNSON & JOHNSON IN 2008

Table 5-25 FORECAST DOLLAR SALES GROWTH FOR NONPRESCRIPTION DRUGS OF JOHNSON & JOHNSON BY CATEGORY, 2008 TO 2013

Johnson & Johnson–Merck [US$ 1 000]

Table 5-26 JOHNSON & JOHNSON–MERCK’S SALES OF NONPRESCRIPTION DRUGS, 2007 AND 2008

Table 5-27 NONPRESCRIPTION DRUGS OF JOHNSON & JOHNSON–MERCK, 2008

Novartis [US$ 2 500]

Table 5-28 NOVARTIS’ SALES OF NONPRESCRIPTION DRUGS, 2007 AND 2008 Table 5 29 NONPRESCRIPTION DRUGS OF NOVARTIS, 2008

Table 5-30 NEW PRODUCTS INTRODUCED BY NOVARTIS IN 2008

Table 5-31 FORECAST DOLLAR SALES GROWTH FOR NONPRESCRIPTION DRUGS OF NOVARTIS BY CATEGORY, 2008 TO 2013

Perrigo Company [US$ 1 000]

Table 5-32 NONPRESCRIPTION DRUGS OF PERRIGO COMPANY AND NATIONAL BRAND EQUIVALENTS, 2008

Prestige Brands [US$ 1 000]

Table 5-33 PRESTIGE BRANDS’ SALES OF NONPRESCRIPTION DRUGS, 2007 AND 2008

Table 5-34 NONPRESCRIPTION DRUGS OF PRESTIGE BRANDS, 2008

Table 5-35 SELECT NEW PRODUCTS INTRODUCED BY PRESTIGE BRANDS IN 2008

Table 5-36 FORECAST DOLLAR SALES GROWTH FOR NONPRESCRIPTION DRUGS OF PRESTIGE BRANDS BY CATEGORY, 2008 TO 2013

Procter & Gamble [US$ 2 500]

Table 5-37 PROCTER & GAMBLE’S SALES OF NONPRESCRIPTION DRUGS, 2007 AND 2008

Table 5-38 NONPRESCRIPTION DRUGS OF PROCTER & GAMBLE, 2008

Table 5-39 SELECT NEW PRODUCTS INTRODUCED BY PROCTER & GAMBLE IN 2008

Table 5-40 FORECAST DOLLAR SALES GROWTH FOR NONPRESCRIPTION DRUGS OF PROCTER & GAMBLE BY CATEGORY, 2008 TO 2013

Reckitt Benckiser [US$ 1 000]

Table 5-41 RECKITT BENCKISER’S SALES OF NONPRESCRIPTION DRUGS, 2007 AND 2008

Table 5-42 NONPRESCRIPTION DRUGS OF RECKITT BENCKISER, 2008

Table 5-43 FORECAST DOLLAR SALES GROWTH FOR NONPRESCRIPTION DRUGS OF RECKITT BENCKISER BY CATEGORY, 2008 TO 2013

Roche Holdings Ltd. [US$ 1 000]

Table 5-44 ROCHE HOLDINGS’ SALES OF NONPRESCRIPTION DRUGS, 2007 AND 2008

Table 5-45 HOME DIAGNOSTIC TEST KITS OF ROCHE HOLDINGS, 2008

Table 5-46 SELECT NEW PRODUCTS INTRODUCED BY ROCHE HOLDINGS IN 2008

Schering Plough [US$ 2 500]

Table 5-47 SCHERING-PLOUGH’S SALES OF NONPRESCRIPTION DRUGS, 2007 AND 2008

Table 5-48 NONPRESCRIPTION DRUGS OF SCHERING-PLOUGH, 2008

Table 5-49 SELECT NEW PRODUCTS INTRODUCED BY SCHERING-PLOUGH IN 2008

Table 5-50 FORECAST DOLLAR GROWTH FOR NONPRESCRIPTION DRUGS OF SCHERING-PLOUGH BY CATEGORY, 2008 TO 2013

Wyeth [US$ 2 500]

Table 5-51 WYETH’S SALES OF NONPRESCRIPTION DRUGS, 2007 AND 2008

Table 5 52 NONPRESCRIPTION DRUGS OF WYETH, 2008

Table 5-53 SELECT NEW PRODUCTS INTRODUCED BY WYETH IN 2008

Table 5-54 FORECAST DOLLAR SALES GROWTH FOR NONPRESCRIPTION DRUGS OF WYETH BY CATEGORY, 2008 TO 2013

MINOR COMPANIES [US$ 5 000]

AIRBORNE HEALTH
ALAN JAMES GROUP
ALBERTO-CULVER
ALLERGAN
ALVA-AMCO PHARMACAL
AMERIFIT NUTRITION
BARR LABORATORIES
BAUSCH & LOMB
B.F. ASCHER
BIOFILM, INC.
BLAINE LABORATORIES
BLAIREX LABORATORIES
BLISTEX, INC.
C.B. FLEET
CV TECHNOLOGIES
CADBURY SCHWEPPES
CARMA LABORATORIES
CHURCH & DWIGHT
COLGATE-PALMOLIVE
COLUMBIA LABORATORIES
COMBE, INC.
DEL LABORATORIES
FLEMING PHARMACEUTICALS
HIMMEL GROUP
HI-TECH PHARMACAL
HISAMITSU AMERICA
IMPROVITA
INSIGHT PHARMACEUTICALS
INVERNESS MEDICAL INNOVATIONS
KONSYL PHARMACEUTICALS
LIL’ DRUG STORE
MATRIXX INITIATIVES
MED-SYSTEMS
MIRALUS HEALTHCARE
NATROL, INC.
NATURE’S WAY
NBTY, INC.
NESTLE
NORTHWEST NATURAL PRODUCTS
OTSUKA PHARMACEUTICAL
PEDIFIX
PRINCE OF PEACE
PURDUE PHARMA, L.P.
QUIGLEY CORPORATION
RICOLA
ROHTO PHARMACEUTICAL COMPANY
SCHIFF NUTRITION
SIMILASAN
STIEFEL LABORATORIES
SUMMERS LABORATORIES
W.F. YOUNG
ZANFEL, INC.

MARKET WATCH BULLETIN [US$ 3 000]

Introduction - Market Watch Bulletin [US$ 0]

Company Developments [US$ 700]

New Products [US$ 2 400]

STEP 2 of 3

– Provide your contact information:

All fields in *BOLD are required.

*Name:
*Title:
*Company/Division:
*Address 1 :
Address 2 :
*City:
*State/Province:
*Zip/Postal code:
*Country:
*Phone:
Fax:
*Email:

STEP 3 of 3

– Review and accept our subscription terms and conditions by viewing and clicking below:

*Please view our terms and conditions, and check this box to indicate your acceptance of these terms and conditions.

Thank you for your interest in subscribing to our syndicated reports. To complete this process, please click on the button below and a member of our global sales team will contact you shortly to confirm the final price and complete the transaction. Upon acceptance of your order, we will deliver the files in PDF format via email.

Market Research: Nonprescription Drugs USA 2008

Nonprescription Drugs USA 2008

ORDER ONLINE

STEP 1 of 3

STEP 2 of 3

STEP 3 of 3

Questions?